Trending...
- Wealthywet's Miami Swim Week 2025 Debut Signals a New Era of Luxury in Swimwear
- BREAKING CONSUMER ALERT: Carvana's "Certified" Luxury SUV Buyer Exposes Legal & Mechanical Trauma 'Presses' Charges of Duress, Deception, and Delay
- Boston Saves Provides Financial Boost to BPS Students, Setting them up Future Success
WOBURN, Mass., Sept. 27, 2024 ~ ProTom International, a leading provider of compact proton therapy technology, has announced the launch of its latest innovation in cancer treatment - the Radiance 330-C Proton Therapy SystemTM. This new system is set to revolutionize the field of proton therapy with its compact and modular design, making it more accessible and cost-effective for healthcare providers.
The Radiance 330-C Single Room Solution offers a fixed-beam room configuration that can be easily integrated into existing radiation oncology departments. This allows for single or multiple-room capabilities within or adjacent to existing Linac vaults, providing flexibility and convenience for healthcare providers. When combined with Leo Cancer Care's upright patient positioning and imaging system, the Radiance 330-C offers gantry-less proton therapy without compromising on treatment capability.
One of the key features of this new system is its Fidelity™ pencil beam scanning technology, which allows for precise dose sculpting. The system also includes an upright patient positioning system and diagnostic quality CT at the treatment isocenter, enabling real-time adaptive therapy. The stationary beam delivery system improves reliability, beam parameters, and accuracy while reducing maintenance costs. Additionally, it boasts a compact synchrotron particle accelerator that can deliver a clinical treatment energy range from 70 MeV to 250 MeV with a capacity of up to 330 MeV for future deployment of proton imaging.
More on Boston Chron
Paul Tso, CEO of ProTom International expressed his excitement about the launch of Radiance 330-C: "We are thrilled to introduce this groundbreaking technology to the world. With Leo's Upright Positioning and Imaging System, Radiance 330-C becomes even more accessible to those who need it but are constrained by space and resources. As promised by ProTom, we are dedicated to providing healthcare providers with a modular, compact, and economically viable proton therapy solution."
Stephen Towe, CEO of Leo Cancer Care also shared his enthusiasm about this partnership: "Our mission has always been to make Proton Therapy available to as many people as possible. By offering our solution in various configurations, we are taking a significant step towards achieving this goal. This partnership with ProTom International showcases the industry's commitment to innovation and breaking down barriers to better care."
It is important to note that the Radiance 330-C Proton Therapy System is not yet available for clinical use. However, with its advanced technology and cost-effective design, it is expected to have a significant impact on the field of cancer treatment once it becomes available.
The Radiance 330-C Single Room Solution offers a fixed-beam room configuration that can be easily integrated into existing radiation oncology departments. This allows for single or multiple-room capabilities within or adjacent to existing Linac vaults, providing flexibility and convenience for healthcare providers. When combined with Leo Cancer Care's upright patient positioning and imaging system, the Radiance 330-C offers gantry-less proton therapy without compromising on treatment capability.
One of the key features of this new system is its Fidelity™ pencil beam scanning technology, which allows for precise dose sculpting. The system also includes an upright patient positioning system and diagnostic quality CT at the treatment isocenter, enabling real-time adaptive therapy. The stationary beam delivery system improves reliability, beam parameters, and accuracy while reducing maintenance costs. Additionally, it boasts a compact synchrotron particle accelerator that can deliver a clinical treatment energy range from 70 MeV to 250 MeV with a capacity of up to 330 MeV for future deployment of proton imaging.
More on Boston Chron
- DivX Enhances AVI Playback Resources; Simplifies Guide to Playing AVI Files with DivX Software
- Patrick Aloni Joins Historic Gold and Copper Discovery in Argentina with Multimillion-Dollar Stake
- Boston: June is Men's Mental Health Awareness Month
- Boston: Happy Juneteenth!
- Boston: Council Denounces Renaming of Navy Ships
Paul Tso, CEO of ProTom International expressed his excitement about the launch of Radiance 330-C: "We are thrilled to introduce this groundbreaking technology to the world. With Leo's Upright Positioning and Imaging System, Radiance 330-C becomes even more accessible to those who need it but are constrained by space and resources. As promised by ProTom, we are dedicated to providing healthcare providers with a modular, compact, and economically viable proton therapy solution."
Stephen Towe, CEO of Leo Cancer Care also shared his enthusiasm about this partnership: "Our mission has always been to make Proton Therapy available to as many people as possible. By offering our solution in various configurations, we are taking a significant step towards achieving this goal. This partnership with ProTom International showcases the industry's commitment to innovation and breaking down barriers to better care."
It is important to note that the Radiance 330-C Proton Therapy System is not yet available for clinical use. However, with its advanced technology and cost-effective design, it is expected to have a significant impact on the field of cancer treatment once it becomes available.
Filed Under: Business
0 Comments
Latest on Boston Chron
- South Shore Food Bank's Epic FOOD FIGHT Fundraiser Set for June 21st
- United States Congressional Candidate Peter Coe Verbica Unveils 25-Point Federal Plan to Help Make California Affordable Again
- D8Averse Launches D8Acapture: Disruptive Mobile-First App Transforms Utility Pole Data Collection
- 2025 Romance Travel Forum Drives Targeted Growth and Industry Collaboration
- Experience Trembling Firsthand with the New AgeMan® Tremor Simulator
- Mauro Schnaidman named as Managing Director in Miami, Florida
- Continued Streak of Recognitions with Multiple Chambers and Partners Rankings
- Anern Shines at SOLAR AFRICA Kenya with Solar Lithium Battery Storage Technology
- Last Call - Submit Your Proposal for the 2025 OpenSSL Conference in Prague
- Robert Michael & Co. Launches New Real Estate Website to Serve Central Florida Homebuyers and Sellers
- IFFA 2025 Shines Bright as Mukesh Modi Welcomes Rio Rocket and Award Winner Lulu Lopez
- Kemeny, Ramp & Renaud Expands Legal Team with Attorney Baruch Kraut
- WOA Entertainment Group Unveils Independent No.1's: Breakthrough Artists II —A Celebration of Indie Excellence
- SheepFeast Launches "1 Million Discipled" Global Initiative to Empower Disciple-Making Around the World
- Sun City Resident Realtor Launches Exclusive Weekly Market Update for Bluffton's 55+ Communities!
- Mythical Man-Fae: A Captivating Adult Coloring Book of Fantasy and Enchantment
- Delta Capital Group, Inc. Earns A+ Rating from the Better Business Bureau, Marking Another Milestone in Explosive Growth
- Mayor Michelle Wu and Office of Youth Engagement and Advancement Celebrate 30 Years of Boston Mayor's Youth Council
- Vice President JD Vance & Industry Leaders at Bitcoin Conference After Partnership Signing to Optimize Cybersecurity Solutions: Bullet Blockchain, Inc
- Actress/Comedian Schelle Purcell Sizzles This Summer with Star-Making Turn in Tyler Perry's #1 Netflix Film, Straw, and Upcoming Comedy Special